Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease

Clinical Trial ID NCT04352803

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04352803

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012 21.04
2 Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001 20.65
3 Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020 9.53
4 Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020 6.59
5 A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020 3.90
6 Immunomodulatory effects of adipose-derived mesenchymal stem cells on the gene expression of major transcription factors of T cell subsets. Int Immunopharmacol 2014 0.82
Next 100